Status:
UNKNOWN
High Resolution Immersion Ultrasound for iIOL Power Calculation
Lead Sponsor:
Prim. Prof. Dr. Oliver Findl, MBA
Conditions:
Cataract
Eligibility:
All Genders
21-105 years
Phase:
NA
Brief Summary
Assess is the additional use of high resolution immersion ultrasound measurements improve the refractive outcome after cataract surgery.
Detailed Description
Since the beginning of biometry, immersion ultrasound was shown to be accurate and reproducible. It is important to distinguish between immersion ultrasound techniques and contact ultrasound. The late...
Eligibility Criteria
Inclusion
- Cataract
- Age 21 and older
- Able to understand the patient information
- Willing to follow the instructions and attend all follow-up visits
- Willing to sign informed consent prior to surgery
Exclusion
- Relevant other ophthalmic diseases that are likely to reduce the refractive outcome, such as pseudoexfoliation syndrome, traumatic cataract, severe corneal scars
- Previous ocular surgeries on the study eye
- Patients who are not able to cooperate, with eccentric fixation or insufficient ability to fixate (tremor, nystagmus)
- Pregnant or lactating women (pregnancy testing will be performed preoperatively on women of reproductive age)
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03749486
Start Date
January 1 2018
End Date
January 1 2020
Last Update
November 21 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vienna Institute for Research in Ocular Surgery (VIROS)
Vienna, Austria, 1140